Huadong Pharmaceuticals (000963.SZ): The registration application for injectable polydioxanone microsphere facial filler medical device has been accepted.

Wisdom Financial News APP News, East China Pharmaceutical (000963.SZ) announced that on June 8, 2026, its wholly-owned subsidiary Xinkeli Mei Xue (Hangzhou) Supply Chain Management Co., Ltd. received a "Notice of Acceptance" issued by the National Medical Products Administration (NMPA) for the change registration application of three types of medical devices, injection poly-caprolactone microspheres facial filler Ellans Ivers S type submitted by its agent, Xi Shi, expanding new indications. This application adds a new indication: for subcutaneous or periosteal implantation in the forehead to improve moderate to severe contour defects in the forehead.